Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Julphar
Boehringer Ingelheim
Farmers Insurance
UBS
Baxter
Accenture
Deloitte
QuintilesIMS

Generated: November 19, 2018

DrugPatentWatch Database Preview

Midostaurin - Generic Drug Details

« Back to Dashboard

What are the generic sources for midostaurin and what is the scope of midostaurin freedom to operate?

Midostaurin is the generic ingredient in one branded drug marketed by Novartis Pharms Corp and is included in one NDA. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

One supplier is listed for this compound.

Pharmacology for midostaurin
Synonyms for midostaurin
[9S-(9?,10?,11?,13?)]-N-(2,3,10,11,12,13-Hexahydro-10-methoxy-9-methyl-1-oxo-9,13-epoxy-1H,9H-diindolo[1,2,3-gh:3',2',1'-lm]pyrrolo[3,4-j][1,7]benzodiazonin-11-yl)-N-methylbenzamide
120685-11-2
4-N-benzoylstaurosporine
4'-N-Benzoylstaurosporine
ACN-036840
AKOS024457372
AN-5669
BDBM31094
BDBM50326053
BDBM50423656
Benzamide,10R,11R,13R)-2,3,10,11,12,13- hexahydro-10-methoxy-9-methyl-1-oxo-9,13-epoxy-1H,9H- diindolo[1,2,3-gh:3',2',1'-lm]pyrrolo[3,4-j][1,7]benzodiazonin-11-yl]-N-methyl-
Benzoylstaurosporine
BMGQWWVMWDBQGC-UHFFFAOYSA-N
BRD-K13646352-001-01-2
C35H30N4O4
CCG-101288
Cgp 41 251
CGP 41231
Cgp 41251
CGP-41251
CGP-41521
CGP41231
CGP41251
CHEBI:63452
CHEBI:91464
CHEMBL608533
cid_24202429
CPG 41251
CS-3331
D05029
D07NVU
D0KL7G
D0V2BO
DB06595
GTPL5702
HY-10230
ID912S5VON
J-004379
KB-75409
MCL-1-specific antisense oligonucleotide + midostaurin(PKC412)
MFCD12828879
Midostaurin (PKC412)
Midostaurin (USAN/INN)
Midostaurin [USAN:INN]
Midostaurin(PKC412)
MolPort-023-276-626
N-[(2S,3R,4R,6R)-3-methoxy-2-methyl-16-oxo-29-oxa-1,7,17-triazaoctacyclo[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]nonacosa-8,10,12,14(28),15(19),20(27),21,23,25-nonaen-4-yl]-N-methylbenzamide
N-[(5S,6R,7R,9R)-6-methoxy-5-methyl-14-oxo-6,7,8,9,15,16-hexahydro-5H,14H-5,9-epoxy-4b,9a,15-triazadibenzo[b,h]cyclonona[1,2,3,4-jkl]cyclopenta[e]-as-indacen-7-yl]-N-methylbenzamide
N-benzoyl-staurosporine
N-Benzoylstaurosporine
NCGC00241102-01
NCGC00241102-02
NSC-656576
NVP-PKC412
PKC 412
PKC-412
PKC412
RYDAPT
Rydapt (TN)
s8064
SCHEMBL13170170
SCHEMBL14342262
SCHEMBL8295379
Staurosporine, N-Benzoyl
UNII-ID912S5VON
X6312
Z-3116
ZINC100013130
ZINC100070719
ZINC100369728

US Patents and Regulatory Information for midostaurin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis Pharms Corp RYDAPT midostaurin CAPSULE;ORAL 207997-001 Apr 28, 2017 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Novartis Pharms Corp RYDAPT midostaurin CAPSULE;ORAL 207997-001 Apr 28, 2017 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Novartis Pharms Corp RYDAPT midostaurin CAPSULE;ORAL 207997-001 Apr 28, 2017 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Novartis Pharms Corp RYDAPT midostaurin CAPSULE;ORAL 207997-001 Apr 28, 2017 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for midostaurin

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0917 Netherlands ➤ Try a Free Trial PRODUCT NAME: MIDOSTAURINE, DESGEWENST IN DE VORM VAN EEN ZOUT; REGISTRATION NO/DATE: EU/1/17/1218 20170920
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Julphar
Boehringer Ingelheim
Farmers Insurance
UBS
Baxter
Accenture
Deloitte
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.